Thank you for sharing!

Your article was successfully shared with the contacts you provided.

NORTH BRUNSWICK, NJ-At a press conference yesterday, acting Gov. Donald DiFrancesco and officials from pharmaceuticals giant Bristol-Myers Squibb, the country’s third largest drug company, confirmed a report by GlobeSt.com that the company was ready to break ground on a major new R&D facility. With the announcement, the price tag for the project was officially put at $235 million.

The project, which will break ground immediately, will be located on the company’s 40-building campus straddling the border of North Brunswick and New Brunswick. Besides the price tag and the fact that the R&D facility will consist of two buildings, few details were released. The operation, however, will create 120 jobs, replacing many of those trimmed last month when Bristol-Myers Squibb shut down its last on-site manufacturing plant.

DiFrancesco’s remarks at the press conference included references to New Jersey’s impact on the pharmaceuticals business. “New Jersey companies create almost 40% of all new drugs approved by the FDA,” he reported, “and we produce half of worldwide drug sales. These companies also commit half of the $29 billion spent annually on pharmaceuticals R&D.” Bristol-Myers Squibb’s R&D budget last year was $2 billion.

Want to continue reading?
Become a Free ALM Digital Reader.

Once you are an ALM digital member, you’ll receive:

  • Unlimited access to GlobeSt and other free ALM publications
  • Access to 15 years of GlobeSt archives
  • Your choice of GlobeSt digital newsletters and over 70 others from popular sister publications
  • 1 free article* every 30 days across the ALM subscription network
  • Exclusive discounts on ALM events and publications

*May exclude premium content
Already have an account?


Join GlobeSt

Don't miss crucial news and insights you need to make informed commercial real estate decisions. Join GlobeSt.com now!

  • Free unlimited access to GlobeSt.com's trusted and independent team of experts who provide commercial real estate owners, investors, developers, brokers and finance professionals with comprehensive coverage, analysis and best practices necessary to innovate and build business.
  • Exclusive discounts on ALM and GlobeSt events.
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com.

Already have an account? Sign In Now
Join GlobeSt

Copyright © 2021 ALM Media Properties, LLC. All Rights Reserved.